A study to see changes after antiVEFG injection ranibizumab in Retinal Vein Occlusion using OCT Angiography patients at SMS hospital

An interventional study to see changes in optical coherence tomography based angiography biomarkers and visual acquity after antivascular endothelial growth factor injection in patients with retinal vein occlusion at SMS Hospital - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/056558

Enrollment

Registered

2023-08-16

Start date

Unknown

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H00-H59- Diseases of the eye and adnexa

Interventions

Intervention1: Anti VEGF Injection (ranibizumab): Inj Ranibizumab 0.5mg/0.05 ml Once When cystoid macular edema detected and repeated monthly till it resolves in 3 months Control Intervention1: CRT a

Eligibility

Inclusion criteria

Inclusion criteria: Recent episode of RVO Presence of Macular Edema Minimum 3 months of follow up Well informed written consent

Exclusion criteria

Exclusion criteria: Uncooperative patients Big media opacity Ocular infection Ocular trauma

Design outcomes

Primary

Measure	Time frame
To compare pre injection & post injection CRT & vessel density in RVO patients after Antivegf injectionTimepoint: baseline before injection 7 days 1 month 3 month	—

Secondary

Measure	Time frame
To compare pre injection & postinjection visual acquityTimepoint: Baseline before injection 7 Days 1 month 3 month	—

Countries

India

Contacts

Public ContactDr Sanjeev Kumar Neiniwal

SMS Medical College and Hospital Jaipur

nainvision@yahoo.com9414707772

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026